Table 2.
Endpoint | NAC (N=133) | Placebo (N=131) | Treatment Difference (95% Confidence Interval) | P-value |
---|---|---|---|---|
Forced vital capacity (liters) | −0.18 | −0.19 | 0.01 (−0.06, 0.09) | 0.77 |
Pre-alert | −0.17 | −0.22 | 0.06 (−0.04, 0.15) | 0.27 |
Post-alert | −0.19 | −0.13 | −0.06 (−0.18, 0.06) | 0.32 |
Carbon monoxide diffusion corrected for hemoglobin (mL/min/mmHg) | −1.3 | −1.4 | 0.2 (−0.4, 0.8) | 0.56 |
Pre-alert | −1.1 | −1.9 | 0.8 (0.1, 1.5) | 0.028 |
Post-alert | −1.4 | −0.8 | −0.7 (−1.6, 0.3) | 0.18 |
6-minute walk test distance (meters) | −23.4 | −47.5 | 24.2 (−2.6, 50.9) | 0.076 |
Pre-alert | −27.2 | −67.7 | 40.5 (6.1, 74.8) | 0.021 |
Post-alert | −14.1 | −15.8 | 1.7 (−38.7, 42.1) | 0.93 |
UCSD shortness of breath questionnaire | 6.0 | 5.8 | 0.2 (−4.1, 4.4) | 0.94 |
Pre-alert | 5.6 | 7.6 | −2.1 (−8.3, 4.2) | 0.52 |
Post-alert | 7.4 | 2.8 | 4.6 (−0.7, 9.8) | 0.086 |
SGRQ – total score | 4.3 | 5.5 | −1.2 (−4.9, 2.4) | 0.51 |
Pre-alert | 4.5 | 7.7 | −3.3 (−8.3, 1.7) | 0.20 |
Post-alert | 4.3 | 2.7 | 1.6 (−3.7, 6.9) | 0.55 |
SF-36: aggregate mental score | 0.0 | −2.6 | 2.6 (0.3, 5.0) | 0.025 |
Pre-alert | 0.8 | −3.5 | 4.3 (1.3, 7.3) | 0.005 |
Post-alert | −1.3 | −1.2 | −0.1 (−3.8, 3.6) | 0.97 |
ICECAP summary score | 0.01 | −0.02 | 0.03 (0.01, 0.05) | 0.013 |
Pre-alert | −0.00 | −0.05 | 0.04 (0.01, 0.08) | 0.008 |
Post-alert | 0.02 | 0.00 | 0.01 (−0.02, 0.05) | 0.40 |
EuroQoL visual analog score | 0.9 | −3.3 | 4.2 (−0.3, 8.8) | 0.069 |
Pre-alert | −1.7 | −7.6 | 5.9 (−0.1, 11.9) | 0.054 |
Post-alert | 4.5 | 1.6 | 2.8 (−3.8, 9.4) | 0.40 |
For each endpoint the first row is the overall result, the second row is the pre-alert cohort, and the third row is the post-alert cohort.
Abbreviations: SGRQ denotes St George’s respiratory questionnaire; EuroQoL denotes EuroQoL Group 5-Dimension; SF-36 denotes the Medical Outcomes Study 36-Item Short-Form Health Survey; and ICECAP denotes ICEpop CAPability measure for Older people.